Publications
334 results found
Frampton AE, Pai M, Krell J, et al., 2012, The "malignant truth" about the recurrence of pancreatic intraductal papillary mucinous neoplasms., Archives of Surgery, Vol: 147, Pages: 977-979
Zhang Y, Frampton AE, Cohen P, et al., 2012, Tumor Infiltration in the Medial Resection Margin Predicts Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma, JOURNAL OF GASTROINTESTINAL SURGERY, Vol: 16, Pages: 1875-1882, ISSN: 1091-255X
- Author Web Link
- Cite
- Citations: 47
Frampton AE, Krell J, Giovannetti E, et al., 2012, Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathways, EXPERT REVIEW OF ANTICANCER THERAPY, Vol: 12, Pages: 1275-1278, ISSN: 1473-7140
- Author Web Link
- Cite
- Citations: 3
Zabron AA, Frampton AE, Krell J, et al., 2012, MicroRNAs in malignant bile as diagnostic biomarkers for pancreatic ductal adenocarcinoma., UEGW, Pages: A119-A119
Panagiotopoulos N, Kyriakides C, Weerakkody RA, et al., 2012, Recurrent Dedifferentiated Liposarcoma Arising from the Small Bowel Mesentery: A Case Report., J Gastrointest Cancer, Vol: 43 Suppl 1, Pages: S175-S177
Mizandari M, Ao G, Zhang Y, et al., 2012, Novel Percutaneous Radiofrequency Ablation of Portal Vein Tumor Thrombus: Safety and Feasibility, Cardiovasc Intervent Radiol.
Kyriakides C, Panagiotopoulos N, Jiao LR, 2012, Isolated Laparoscopic Caudate Lobe Resection, SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, Vol: 22, Pages: E209-E209, ISSN: 1530-4515
- Author Web Link
- Cite
- Citations: 13
Krell J, Frampton AE, Jiao LR, et al., 2012, Can pharmacogenomics guide effective anticancer therapy in pancreatic ductal adenocarcinoma?, PHARMACOGENOMICS, Vol: 13, Pages: 977-979, ISSN: 1462-2416
- Author Web Link
- Cite
- Citations: 1
Frampton AE, Krell J, Jacob J, et al., 2012, Loss of miR-126 is crucial to pancreatic cancer progression, EXPERT REVIEW OF ANTICANCER THERAPY, Vol: 12, Pages: 881-884, ISSN: 1473-7140
- Author Web Link
- Cite
- Citations: 37
Zhang Y, Frampton AE, Kyriakides C, et al., 2012, Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, Vol: 138, Pages: 1063-1071, ISSN: 0171-5216
- Author Web Link
- Cite
- Citations: 48
Zhang Y, Huang J, Chen M, et al., 2012, Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: A meta-analysis, PANCREATOLOGY, Vol: 12, Pages: 227-233, ISSN: 1424-3903
- Author Web Link
- Cite
- Citations: 26
Kallis Y, Phillips N, Steel A, et al., 2012, Radiofrequency Ablation for Biliary Metal Stent Occlusion: Evolution of a Novel Endoscopic Technique and Proof of Concept, Digestive Disease Week (DDW), Publisher: MOSBY-ELSEVIER, Pages: 377-378, ISSN: 0016-5107
- Author Web Link
- Cite
- Citations: 6
Pai M, Frampton AE, Mikhail S, et al., 2012, Radiofrequency assisted liver resection: Analysis of 604 consecutive cases., Eur J Surg Oncol., Vol: 38, Pages: 274-280
Frampton AE, Krell J, Pellegrino L, et al., 2012, Integrated analysis of miRNA and mRNA profiles enables target acquisition in human cancers, EXPERT REVIEW OF ANTICANCER THERAPY, Vol: 12, Pages: 323-330, ISSN: 1473-7140
- Author Web Link
- Cite
- Citations: 2
Jiao LR, Frampton AE, Jacob J, et al., 2012, MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors, PLOS ONE, Vol: 7, ISSN: 1932-6203
- Author Web Link
- Open Access Link
- Cite
- Citations: 109
Kayani B, Spalding DR, Jiao LR, et al., 2012, Does neostigmine improve time to resolution of symptoms in acute colonic pseudo-obstruction?, INTERNATIONAL JOURNAL OF SURGERY, Vol: 10, Pages: 453-457, ISSN: 1743-9191
- Author Web Link
- Cite
- Citations: 16
Pai M, Spalding D, Jiao L, et al., 2012, Use of Bipolar Radiofrequency in Parenchymal Transection of the Liver, Pancreas and Kidney, DIGESTIVE SURGERY, Vol: 29, Pages: 43-47, ISSN: 0253-4886
- Author Web Link
- Cite
- Citations: 21
Krell J, Frampton AE, Jacob J, et al., 2012, The Clinico-Pathologic Role of MicroRNAs miR-9 and miR-151-5p in Breast Cancer Metastasis, MOLECULAR DIAGNOSIS & THERAPY, Vol: 16, Pages: 167-172, ISSN: 1177-1062
- Author Web Link
- Cite
- Citations: 35
Panagiotopoulos N, Acharya M, Ahmad R, et al., 2012, Epithelial inclusion cyst arising within an intra-pancreatic splenunculus., Int J Surg Case Rep, Vol: 3, Pages: 118-120
INTRODUCTION: An accessory spleen (splenunculus) may occur in up to 10% of the general population. However, an epithelial inclusion cyst originating within an intra-pancreatic splenunculus is an extremely rare finding, with only twenty-two previous cases described in medical literature. PRESENTATION OF CASE: A 51-year-old male presented to our institution for investigation of altered bowel habit. Endoscopic ultrasound examination and CT scanning demonstrated an 18 mm cystic, well-demarcated lesion in the tail of the pancreas, resembling malignancy. Following laparoscopic spleen-preserving distal pancreatectomy, histological analysis confirmed epithelial inclusion cyst arising within an intra-pancreatic splenunculus. DISCUSSION: The pre-operative radiological identification of such cystic pancreatic lesions is challenging. Surgical resection is usually performed for clinical suspicion of pancreatic malignancy. CONCLUSION: Epithelial inclusion cyst originating within an intra-pancreatic accessory spleen is an extremely rare finding, which can mimic malignancy. Nevertheless, it should be carefully considered in the differential diagnosis of cystic lesions of the tail of the pancreas.
Frampton AE, Krell J, Jacob J, et al., 2011, microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma, EXPERT REVIEW OF ANTICANCER THERAPY, Vol: 11, Pages: 1837-1842, ISSN: 1473-7140
- Author Web Link
- Cite
- Citations: 21
Mallappa S, Jiao LR, 2011, Juxtapapillary duodenal diverticulum masquerading as a cystic pancreatic neoplasm., JRSM Short Rep, Vol: 2
Pai M, Kyriakides C, Mikhail S, et al., 2011, Radiofrequency-Assisted Hepatic Resection, ANNALS OF SURGICAL ONCOLOGY, Vol: 18, Pages: 3391-3391, ISSN: 1068-9265
- Author Web Link
- Cite
- Citations: 6
Kallis YN, Phillips N, Steel A, et al., 2011, FIRST REPORT OF THE LONG TERM EFFICACY OF A NOVEL ENDOSCOPIC RADIOFREQUENCY ABLATION TECHNIQUE FOR MALIGNANT BILIARY OBSTRUCTION, 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Publisher: WILEY-BLACKWELL, Pages: 1365A-1366A, ISSN: 0270-9139
Lauretta A, Almoudaris AM, Jiao LR, 2011, Septic Thrombophlebitis of Portal Vein: Unusual Presentation of Appendicitis, AMERICAN SURGEON, Vol: 77, Pages: E206-E207, ISSN: 0003-1348
- Author Web Link
- Cite
- Citations: 2
Kallis Y, Phillips N, Steel A, et al., 2011, FIRST REPORT OF THE LONG-TERM EFFICACY OF A NOVEL ENDOSCOPIC RADIOFREQUENCY ABLATION TECHNIQUE FOR MALIGNANT BILIARY OBSTRUCTION, GUT, Vol: 60, Pages: A9-A9, ISSN: 0017-5749
- Author Web Link
- Cite
- Citations: 1
Feng X, Pai M, Mizandari M, et al., 2011, Towards the optimization of management of hepatocellular carcinoma., Front Med, Vol: 5, Pages: 271-276
Hepatocellular carcinoma (HCC) is the fifth most common neoplasm in the world, closely correlated with viral hepatitis and liver cirrhosis. The vast majority of HCC patients present at a late stage and are unsuitable for surgery due to limited liver functional reserve. Tumors can involve major vessels or hilar structures, necessitating major liver resection and/or rendering liver resection unfeasible. A series of new technologies have been developed to optimise HCC management. Stem cell therapy improves impaired liver functional reserve prior to liver resection. Intravascular radiofrequency ablation recanalises the portal vein invaded by tumour thrombus and endobiliary radiofrequency ablation restores and extends biliary patency of the bile duct invaded by malignancy. Laparoscopic radiofrequency assisted liver resection minimizes blood loss and avoids liver warm ischemia, while increasing parenchymal sparing. These benefits combined maximize the safety of liver resection.
Jacob J, Krell J, Castellano L, et al., 2011, Determination of cut-offs for circulating tumor cell measurement in metastatic cancer, EXPERT REVIEW OF ANTICANCER THERAPY, Vol: 11, Pages: 1345-1350, ISSN: 1473-7140
- Author Web Link
- Cite
- Citations: 9
Tsim N, Healey AJ, Frampton AE, et al., 2011, Two-Stage Resection for Bilobar Colorectal Liver Metastases: R0 Resection Is the Key, ANNALS OF SURGICAL ONCOLOGY, Vol: 18, Pages: 1939-1946, ISSN: 1068-9265
- Author Web Link
- Cite
- Citations: 39
Bitsakou G, Frampton AE, Pai M, et al., 2011, An Alternative Pancreatic Anastomosis Following Pancreaticoduodenectomy, ARCHIVES OF SURGERY, Vol: 146, Pages: 752-754, ISSN: 0004-0010
- Author Web Link
- Cite
- Citations: 3
McGuigan C, Habib NA, Wasan HS, et al., 2011, A phosphoramidate ProTide (NUC-1031) and acquired and intrinsic resistance to gemcitabine, JOURNAL OF CLINICAL ONCOLOGY, Vol: 29, ISSN: 0732-183X
- Author Web Link
- Cite
- Citations: 7
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.